Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis

P. H. Hofschneider, U. Winter, E. M. Lemmel, B. Brölz, W. Gaus, S. Schmid, H. J. Obert, C. Stetter, I. O. Auer, C. Papst, W. H. Boesken, H. E. Stierle, U. Botzenhardt, W. Reemtsen, D. Brackertz, D. Richter, V. Diehl, A. K. von Kalle, C. Gärtner, S. HerzigJ. Goronzy, C. Weyand, J. R. Kalden, F. Strobel, K. Machalke, H. H. Peter, S. Meske, M. Schattenkirchner, K. Krüger, R. Sprekeler, H. D. Waller, J. G. Saal, H. Warnatz, G. Lemm, K. Wilms, T. Stolzenburg

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences